Gland Pharma Board Meeting May 15 FY26 Results

Gland Pharma Limited intimates its Board meeting on May 15, 2026 to approve audited standalone and consolidated FY26 results.
The Board will also consider recommending a final dividend for the financial year 2025-26.
The closed trading window for insiders will reopen on May 18, 2026, post-results declaration.
An investor/analyst earnings call is scheduled for 18:30 IST on the day of the Board meeting.